| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 8.01e-06 | 2 | 57 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 8.01e-06 | 2 | 57 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 1.67e-04 | 7 | 57 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.83e-04 | 120 | 57 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | IgG binding | 4.33e-04 | 11 | 57 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 6.09e-04 | 58 | 57 | 3 | GO:0051018 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 7.13e-04 | 14 | 57 | 2 | GO:0019763 | |
| GeneOntologyMolecularFunction | phosphatase binding | 9.29e-04 | 264 | 57 | 5 | GO:0019902 | |
| GeneOntologyMolecularFunction | protein kinase A catalytic subunit binding | 9.36e-04 | 16 | 57 | 2 | GO:0034236 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.62e-03 | 21 | 57 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 2.30e-03 | 25 | 57 | 2 | GO:0034237 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 2.84e-03 | 206 | 57 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | protein kinase binding | 3.20e-03 | 873 | 57 | 8 | GO:0019901 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.13e-05 | 313 | 56 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | NRG1 CDH20 ANK3 CD300A MINK1 CRTAM PKD1 DCHS1 DLG3 CLSTN1 IL1RAP EP300 | 2.55e-05 | 1077 | 56 | 12 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of phagocytosis, engulfment | 3.68e-05 | 24 | 56 | 3 | GO:0060099 | |
| GeneOntologyBiologicalProcess | regulation of membrane invagination | 4.18e-05 | 25 | 56 | 3 | GO:1905153 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 6.80e-05 | 257 | 56 | 6 | GO:0007163 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte mediated immunity | 6.94e-05 | 81 | 56 | 4 | GO:0002886 | |
| GeneOntologyBiologicalProcess | type III hypersensitivity | 7.20e-05 | 5 | 56 | 2 | GO:0001802 | |
| GeneOntologyBiologicalProcess | regulation of type III hypersensitivity | 7.20e-05 | 5 | 56 | 2 | GO:0001803 | |
| GeneOntologyBiologicalProcess | positive regulation of type III hypersensitivity | 7.20e-05 | 5 | 56 | 2 | GO:0001805 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 1.32e-04 | 418 | 56 | 7 | GO:0009895 | |
| GeneOntologyBiologicalProcess | definitive erythrocyte differentiation | 2.01e-04 | 8 | 56 | 2 | GO:0060318 | |
| GeneOntologyBiologicalProcess | response to interleukin-1 | 2.43e-04 | 112 | 56 | 4 | GO:0070555 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | GRIP1 NRG1 FCGR1A FCGR1BP FES RICTOR KIF3C POLDIP2 CLSTN1 IL1RAP SMCR8 EP300 | 2.48e-04 | 1366 | 56 | 12 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 3.21e-04 | 10 | 56 | 2 | GO:0001798 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 3.21e-04 | 10 | 56 | 2 | GO:0002894 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 9.16e-05 | 164 | 58 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.42e-04 | 451 | 58 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.39e-04 | 477 | 58 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | A band | 4.07e-04 | 52 | 58 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 4.66e-04 | 503 | 58 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 5.88e-04 | 523 | 58 | 7 | GO:0098984 | |
| MousePheno | polyhydramnios | 4.72e-05 | 3 | 56 | 2 | MP:0004020 | |
| MousePheno | abnormal kidney collecting duct morphology | 5.84e-05 | 53 | 56 | 4 | MP:0004754 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 1.02e-04 | 23 | 56 | 3 | MP:0004088 | |
| MousePheno | abnormal heart septum morphology | 1.45e-04 | 388 | 56 | 8 | MP:0006113 | |
| MousePheno | decreased susceptibility to autoimmune hemolytic anemia | 1.56e-04 | 5 | 56 | 2 | MP:0004828 | |
| Domain | DUF4062 | 8.83e-06 | 2 | 56 | 2 | PF13271 | |
| Domain | DUF4062 | 8.83e-06 | 2 | 56 | 2 | IPR025139 | |
| Domain | IG | 3.44e-05 | 421 | 56 | 8 | SM00409 | |
| Domain | Ig_sub | 3.44e-05 | 421 | 56 | 8 | IPR003599 | |
| Domain | IG_LIKE | 1.01e-04 | 491 | 56 | 8 | PS50835 | |
| Domain | Ig-like_dom | 1.19e-04 | 503 | 56 | 8 | IPR007110 | |
| Domain | - | 1.44e-04 | 663 | 56 | 9 | 2.60.40.10 | |
| Domain | Ig-like_fold | 2.31e-04 | 706 | 56 | 9 | IPR013783 | |
| Domain | IGc2 | 6.85e-04 | 235 | 56 | 5 | SM00408 | |
| Domain | Ig_sub2 | 6.85e-04 | 235 | 56 | 5 | IPR003598 | |
| Domain | ZZ | 1.31e-03 | 18 | 56 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.31e-03 | 18 | 56 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.31e-03 | 18 | 56 | 2 | PS01357 | |
| Domain | Znf_ZZ | 1.46e-03 | 19 | 56 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.46e-03 | 19 | 56 | 2 | SM00291 | |
| Domain | ig | 2.52e-03 | 190 | 56 | 4 | PF00047 | |
| Domain | Immunoglobulin | 2.52e-03 | 190 | 56 | 4 | IPR013151 | |
| Domain | ETS_DOMAIN_1 | 3.17e-03 | 28 | 56 | 2 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 3.17e-03 | 28 | 56 | 2 | PS00346 | |
| Domain | ETS | 3.17e-03 | 28 | 56 | 2 | SM00413 | |
| Domain | Ets_dom | 3.17e-03 | 28 | 56 | 2 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 3.17e-03 | 28 | 56 | 2 | PS50061 | |
| Domain | Ets | 3.17e-03 | 28 | 56 | 2 | PF00178 | |
| Domain | CADHERIN_1 | 4.74e-03 | 113 | 56 | 3 | PS00232 | |
| Domain | Cadherin | 4.74e-03 | 113 | 56 | 3 | PF00028 | |
| Domain | CADHERIN_2 | 4.85e-03 | 114 | 56 | 3 | PS50268 | |
| Domain | - | 4.85e-03 | 114 | 56 | 3 | 2.60.40.60 | |
| Domain | CA | 4.97e-03 | 115 | 56 | 3 | SM00112 | |
| Domain | Cadherin-like | 5.09e-03 | 116 | 56 | 3 | IPR015919 | |
| Domain | Cadherin | 5.34e-03 | 118 | 56 | 3 | IPR002126 | |
| Pubmed | 1.97e-06 | 15 | 58 | 3 | 23345428 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.01e-06 | 123 | 58 | 5 | 26912792 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 28814603 | ||
| Pubmed | Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan. | 2.73e-06 | 2 | 58 | 2 | 37733444 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 28289219 | ||
| Pubmed | Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice. | 2.73e-06 | 2 | 58 | 2 | 35273604 | |
| Pubmed | IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice. | 2.73e-06 | 2 | 58 | 2 | 16305642 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 9257847 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21124939 | ||
| Pubmed | Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. | 2.73e-06 | 2 | 58 | 2 | 24430180 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 17975830 | ||
| Pubmed | Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. | 2.73e-06 | 2 | 58 | 2 | 38885133 | |
| Pubmed | Novel Fc gamma receptor I family gene products in human mononuclear cells. | 2.73e-06 | 2 | 58 | 2 | 1430234 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15835266 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8663283 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 25231998 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 30190171 | ||
| Pubmed | Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. | 2.73e-06 | 2 | 58 | 2 | 2136886 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 1830050 | ||
| Pubmed | FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway. | 2.73e-06 | 2 | 58 | 2 | 30552619 | |
| Pubmed | Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice. | 2.73e-06 | 2 | 58 | 2 | 35833115 | |
| Pubmed | Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain. | 2.73e-06 | 2 | 58 | 2 | 15528358 | |
| Pubmed | Functional characteristics of the high affinity IgG receptor, FcγRI. | 2.73e-06 | 2 | 58 | 2 | 21325219 | |
| Pubmed | Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis. | 2.73e-06 | 2 | 58 | 2 | 14991835 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 1402657 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8611682 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16409296 | ||
| Pubmed | Mouse FcgammaRI: identification and functional characterization of five new alleles. | 2.73e-06 | 2 | 58 | 2 | 10752630 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 30744065 | ||
| Pubmed | Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. | 2.73e-06 | 2 | 58 | 2 | 17124586 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16581781 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 31211699 | ||
| Pubmed | Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. | 2.73e-06 | 2 | 58 | 2 | 8480181 | |
| Pubmed | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. | 2.73e-06 | 2 | 58 | 2 | 29576375 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18245810 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16849450 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8478020 | ||
| Pubmed | FcγR-binding affinity of monoclonal murine IgG1s carrying different N-linked Fc oligosaccharides. | 2.73e-06 | 2 | 58 | 2 | 31554601 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 38524127 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8077658 | ||
| Pubmed | The involvement of FcR mechanisms in antibody-mediated rejection. | 2.73e-06 | 2 | 58 | 2 | 18049118 | |
| Pubmed | SENP1 ABCF1 ANK3 MINK1 NAT10 LRPAP1 RICTOR AKAP11 POLDIP2 SMCR8 LETM1 AKAP12 | 5.13e-06 | 1487 | 58 | 12 | 33957083 | |
| Pubmed | 5.30e-06 | 777 | 58 | 9 | 35844135 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 7806222 | ||
| Pubmed | Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. | 8.19e-06 | 3 | 58 | 2 | 16841095 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12427132 | ||
| Pubmed | MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I. | 8.19e-06 | 3 | 58 | 2 | 22287715 | |
| Pubmed | Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice. | 8.19e-06 | 3 | 58 | 2 | 23898046 | |
| Pubmed | CMYA5 establishes cardiac dyad architecture and positioning. | 8.19e-06 | 3 | 58 | 2 | 35449169 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22003208 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12594281 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15880819 | ||
| Pubmed | Expression of ERβ and its co-regulators p300 and NCoR in human transitional cell bladder cancer. | 8.19e-06 | 3 | 58 | 2 | 21525722 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 28924242 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 9892619 | ||
| Pubmed | PKA compartmentalization via AKAP220 and AKAP12 contributes to endothelial barrier regulation. | 8.19e-06 | 3 | 58 | 2 | 25188285 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30636035 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26056254 | ||
| Pubmed | The essential role of complement in antibody-mediated resistance to Salmonella. | 8.19e-06 | 3 | 58 | 2 | 30179254 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 8697799 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23728777 | ||
| Pubmed | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation. | 8.19e-06 | 3 | 58 | 2 | 22493081 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16543474 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24161960 | ||
| Pubmed | Neuregulin-1-stimulated phosphorylation of GABP in skeletal muscle cells. | 8.19e-06 | 3 | 58 | 2 | 11318655 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12707052 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19657115 | ||
| Pubmed | Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection. | 8.19e-06 | 3 | 58 | 2 | 33032297 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 9763663 | ||
| Pubmed | C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes. | 8.19e-06 | 3 | 58 | 2 | 28432146 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30297432 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12875993 | ||
| Pubmed | Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. | 8.19e-06 | 3 | 58 | 2 | 15701643 | |
| Pubmed | SENP1 ZNF827 NAT10 SCAPER RICTOR YTHDC2 POLDIP2 TEP1 EP300 ZMYM3 | 1.43e-05 | 1116 | 58 | 10 | 31753913 | |
| Pubmed | 1.56e-05 | 29 | 58 | 3 | 26097038 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 9551950 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 19622798 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 19339993 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 17182593 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 16517729 | ||
| Pubmed | Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal. | 1.64e-05 | 4 | 58 | 2 | 29511065 | |
| Pubmed | Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR). | 1.64e-05 | 4 | 58 | 2 | 17073437 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 21169548 | ||
| Pubmed | Evidence for Cd101 but not Fcgr1 as candidate for type 1 diabetes locus, Idd10. | 1.64e-05 | 4 | 58 | 2 | 15850792 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 31562320 | ||
| Pubmed | Fc receptor regulation of protective immunity against Chlamydia trachomatis. | 1.64e-05 | 4 | 58 | 2 | 11872097 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 10760808 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 9490697 | ||
| Pubmed | Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. | 1.64e-05 | 4 | 58 | 2 | 16455953 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 1379234 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 12517949 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 16452176 | ||
| Pubmed | The mouse Fc receptor for IgG (Ly-17): molecular cloning and specificity. | 1.64e-05 | 4 | 58 | 2 | 2957319 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 9849963 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 28028748 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 11997499 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 15485887 | ||
| Pubmed | Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. | 1.64e-05 | 4 | 58 | 2 | 12898452 | |
| Pubmed | Postsynaptic chromatin is under neural control at the neuromuscular junction. | 1.64e-05 | 4 | 58 | 2 | 17304221 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 10770797 | ||
| Interaction | NUP43 interactions | 7.53e-06 | 625 | 56 | 10 | int:NUP43 | |
| Interaction | AJUBA interactions | 9.82e-06 | 103 | 56 | 5 | int:AJUBA | |
| Interaction | FEV interactions | 2.07e-05 | 203 | 56 | 6 | int:FEV | |
| Interaction | KLF3 interactions | 3.97e-05 | 228 | 56 | 6 | int:KLF3 | |
| Cytoband | 15q24 | 3.24e-04 | 21 | 58 | 2 | 15q24 | |
| Cytoband | Xq13.1 | 1.70e-03 | 48 | 58 | 2 | Xq13.1 | |
| Cytoband | 15q26.1 | 2.15e-03 | 54 | 58 | 2 | 15q26.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q26 | 2.29e-03 | 206 | 58 | 3 | chr15q26 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 5.74e-05 | 29 | 47 | 3 | 396 | |
| GeneFamily | Cadherin related | 8.77e-04 | 17 | 47 | 2 | 24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.85e-04 | 18 | 47 | 2 | 91 | |
| GeneFamily | ETS transcription factor family | 2.39e-03 | 28 | 47 | 2 | 534 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.08e-03 | 41 | 47 | 2 | 1298 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.44e-03 | 161 | 47 | 3 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.73e-03 | 163 | 47 | 3 | 590 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.16e-02 | 181 | 47 | 3 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.28e-02 | 66 | 47 | 2 | 722 | |
| GeneFamily | Immunoglobulin like domain containing | 1.38e-02 | 193 | 47 | 3 | 594 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.99e-09 | 188 | 58 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.21e-09 | 194 | 58 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 6.21e-09 | 194 | 58 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.82e-07 | 191 | 58 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.17e-06 | 174 | 58 | 5 | eaaf17a06efc09ed4752b449827b1f0f424d3dad | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-06 | 179 | 58 | 5 | 61dbfc1b9b0344c06a68142c181cd62993556a67 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Pleural_Mac|metastatic_Brain / Location, Cell class and cell subclass | 3.74e-06 | 180 | 58 | 5 | 7de1c8ab1152fa517c6b4830d93ff53a19fca3d7 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.95e-06 | 182 | 58 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.39e-06 | 186 | 58 | 5 | 064b6047215597465bb51a8a1547ef5a226552f9 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 4.75e-06 | 189 | 58 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-06 | 189 | 58 | 5 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.75e-06 | 189 | 58 | 5 | 984b5f21e84dd8273d8437ac2a5a9de4e9484b9a | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-06 | 189 | 58 | 5 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.75e-06 | 189 | 58 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.87e-06 | 190 | 58 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.87e-06 | 190 | 58 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 191 | 58 | 5 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 191 | 58 | 5 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 5.12e-06 | 192 | 58 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.25e-06 | 193 | 58 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.25e-06 | 193 | 58 | 5 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_Macrophage|Trachea / Age, Tissue, Lineage and Cell class | 5.39e-06 | 194 | 58 | 5 | 3c4ac5f91b10802990b84db3406f5e71f8ee8b74 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.52e-06 | 195 | 58 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.52e-06 | 195 | 58 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-06 | 199 | 58 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.95e-05 | 122 | 58 | 4 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.15e-05 | 148 | 58 | 4 | d3ea907f8f408e9bb97ed223a3089e403e35f911 | |
| ToppCell | Immune_cells-Monocytes|World / Lineage and Cell class | 4.15e-05 | 148 | 58 | 4 | e8037e831a6b11b06073b4e76684eb61308822f1 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.49e-05 | 151 | 58 | 4 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 158 | 58 | 4 | ef5feb48161c339c7b71c576bdda61479d29dfac | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 158 | 58 | 4 | c6e64b9b3342e37d54baadae8fb7dfb5d246e4cf | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 161 | 58 | 4 | 441ebd3c029861d833fbcf8a68fc740d9de8ef2f | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 161 | 58 | 4 | 787f91f906756ef570c0d02936c3cdfafb3f7454 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 161 | 58 | 4 | 3db97af49520dc8cbafb4454d8afd9d588160e89 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 161 | 58 | 4 | f1d258c81bcf0f3c52bd20aa58faa9a5fd888168 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.05e-05 | 163 | 58 | 4 | 004765e016c5658ee4a8bda4899804303064727b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.05e-05 | 163 | 58 | 4 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.34e-05 | 165 | 58 | 4 | 354978d4f35154d7b2e36e94de669e045adef512 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.49e-05 | 166 | 58 | 4 | 75d719617c61409860f298ce91cbe3a0aafa0553 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 6.49e-05 | 166 | 58 | 4 | ba42349a68b22e91a0340bda1ccecd6c7592392f | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.64e-05 | 167 | 58 | 4 | d62d5dec30d006a9cc8f3bc5ccc578e10f105027 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.80e-05 | 168 | 58 | 4 | ba9ddd403ee6d6af2fe56dffbd419764bfb703e4 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.80e-05 | 168 | 58 | 4 | 3d8c431a3c8899383212fe6a7627889c40c5f3ef | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.80e-05 | 168 | 58 | 4 | af4c35c0d3f030cef8397c35fa498a71112bb16b | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.80e-05 | 168 | 58 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.12e-05 | 170 | 58 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.28e-05 | 171 | 58 | 4 | 22ad6de44e1d3f72a3d78d46fd26a5743a4f84a5 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | 35d09640d5b04fa0bbb1b40d4b8f97da587a5046 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | 98cb64e2a768908105701a7a5b58f336036250fd | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.45e-05 | 172 | 58 | 4 | a53c906539557594ef10368bc29aec4af063fd37 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 9019049b1e2a24cb0bbbc620d64ef29dd18cc4c6 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 077029eecfe636a5baf5f70464e1713b3f6b4274 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 2e683ec555dc0036875e0f5674dcc5e93ead205d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.62e-05 | 173 | 58 | 4 | 9acad7ec70f713fe3db6cef7bbe3b183bf16ae67 | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 7.62e-05 | 173 | 58 | 4 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.79e-05 | 174 | 58 | 4 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | IPF-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 7.96e-05 | 175 | 58 | 4 | b6d1e40d9339426d778481fd67ab7cbc0f6cb5b2 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 7.96e-05 | 175 | 58 | 4 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 175 | 58 | 4 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 175 | 58 | 4 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 175 | 58 | 4 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.14e-05 | 176 | 58 | 4 | 8f9d2a763b79cafe26dcbf3dba980d473a0b9873 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.14e-05 | 176 | 58 | 4 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.14e-05 | 176 | 58 | 4 | 3b5d12d5c22e32fbe80c3716ff14a7ae5769c165 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-05 | 177 | 58 | 4 | cdad5a2f672a7f07c05669bfcaf1ec74defd3de7 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-05 | 177 | 58 | 4 | 991ae76bb615392d84aeb89886148fa42c1c649c | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 8.32e-05 | 177 | 58 | 4 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.32e-05 | 177 | 58 | 4 | 1e7b4c0e41649d57a2c219a3b7e693538b8b34e4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.32e-05 | 177 | 58 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.51e-05 | 178 | 58 | 4 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | be8af4d85b8835a85a168639c37857dcaa6b00bf | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 8.51e-05 | 178 | 58 | 4 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.69e-05 | 179 | 58 | 4 | 66afd54428e6dcadc3e341faecfde42be4fb5905 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.69e-05 | 179 | 58 | 4 | dc03b9045510eb1bb934329646bb92dd06890ce9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.69e-05 | 179 | 58 | 4 | fa58fa0901eadb170e3d2facb2a3d8c5e624329a | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.69e-05 | 179 | 58 | 4 | 330c1326ba93bb8f32559ee1cc40e357cc44ad8d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.69e-05 | 179 | 58 | 4 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 180 | 58 | 4 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.07e-05 | 181 | 58 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.27e-05 | 182 | 58 | 4 | 1fb9bdf2e9f0a9c230f109b471672f9c31e27c82 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 182 | 58 | 4 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 182 | 58 | 4 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-05 | 183 | 58 | 4 | b12b89debc9dd6396188bc8fe44f54c01c560966 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-05 | 183 | 58 | 4 | 19cc0009f5332b6e4d4274df123eebbfc80b669a | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.67e-05 | 184 | 58 | 4 | ba260f8a2e6e510141a6b9c458eb0040acff0352 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.67e-05 | 184 | 58 | 4 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 9.67e-05 | 184 | 58 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.67e-05 | 184 | 58 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.87e-05 | 185 | 58 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 185 | 58 | 4 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.87e-05 | 185 | 58 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.87e-05 | 185 | 58 | 4 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.87e-05 | 185 | 58 | 4 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 186 | 58 | 4 | 6575ec6a626cdea169ffd185d47828dfaa29475d | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 186 | 58 | 4 | ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A | 6.53e-07 | 196 | 58 | 7 | 1843_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 9.92e-06 | 194 | 58 | 6 | 1217_DN | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.02e-05 | 195 | 58 | 6 | 7033_UP | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.08e-05 | 197 | 58 | 6 | 2061_UP | |
| Drug | Cosopt | 2.48e-05 | 341 | 58 | 7 | CID000003154 | |
| Disease | peak expiratory flow | 5.35e-05 | 498 | 58 | 7 | EFO_0009718 | |
| Disease | vital capacity | 1.34e-04 | 1236 | 58 | 10 | EFO_0004312 | |
| Disease | dementia (is_implicated_in) | 2.47e-04 | 12 | 58 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | Fetal Alcohol Spectrum Disorders | 2.92e-04 | 13 | 58 | 2 | C2985290 | |
| Disease | plasma beta-amyloid 1-42 measurement | 2.92e-04 | 13 | 58 | 2 | EFO_0005660 | |
| Disease | Fetal Alcohol Syndrome | 5.07e-04 | 17 | 58 | 2 | C0015923 | |
| Disease | Cannabis use, age at onset | 6.36e-04 | 19 | 58 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | forced expiratory volume | 8.75e-04 | 789 | 58 | 7 | EFO_0004314 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 1.39e-03 | 28 | 58 | 2 | DOID:8466 (biomarker_via_orthology) | |
| Disease | multiple myeloma | 1.41e-03 | 112 | 58 | 3 | EFO_0001378 | |
| Disease | hormone measurement, thyroid stimulating hormone measurement | 1.49e-03 | 29 | 58 | 2 | EFO_0004730, EFO_0004748 | |
| Disease | bipolar disorder (is_implicated_in) | 1.49e-03 | 29 | 58 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | Mental Retardation, X-Linked | 1.49e-03 | 29 | 58 | 2 | C1136249 | |
| Disease | urate measurement | 1.81e-03 | 895 | 58 | 7 | EFO_0004531 | |
| Disease | Lung Neoplasms | 1.84e-03 | 265 | 58 | 4 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.87e-03 | 266 | 58 | 4 | C0242379 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTVRVVHASDKTVEV | 1321 | Q09472 | |
| AVIVVSHDARLITET | 791 | Q8NE71 | |
| EAETHSVLLTAVESR | 306 | Q96KC9 | |
| EDTSTVTIATEVHPA | 1006 | Q86TB3 | |
| VAEVHVSTVEERTEE | 416 | Q02952 | |
| EVIVDETSDHTEETS | 241 | Q676U5 | |
| VVASSEIHVEVERTS | 396 | Q8IY22 | |
| ETSTVRVETSSHRVE | 21 | A8MU93 | |
| SAAVVHTIVNETLES | 876 | Q9UKA4 | |
| VASVQATVELETSHI | 296 | O94985 | |
| ETLSRTEEIHENVIS | 191 | P30533 | |
| IRLTSEHTVETLVVA | 226 | Q8TE56 | |
| ESSLSVTVHESIEQL | 631 | Q9ULI1 | |
| NVISSEHIVEREAET | 316 | Q02297 | |
| SDVHRETTENIRVTV | 231 | Q9Y2S7 | |
| VSVFQEETVTLHCEV | 31 | Q92637 | |
| TVEVTVRVADINDHA | 126 | Q96JQ0 | |
| DITIDVTINESISHS | 291 | Q9NPH3 | |
| VTINESISHSRTEDE | 296 | Q9NPH3 | |
| HITTISDETSEQVTR | 151 | Q06546 | |
| EIRVLQSHISDTSVV | 246 | O43790 | |
| ETSDILQRVVVHVFS | 301 | Q14164 | |
| HISTSQVAEIVATLE | 701 | O95202 | |
| EVSSRSHAIFIITVE | 211 | O14782 | |
| TSVEESRITRAEVIT | 7156 | Q7Z5P9 | |
| EHTVILAVVSRVSDD | 206 | O95263 | |
| VITNSDDHISVRATI | 411 | Q6R327 | |
| HTVSSEAVSLLEEVI | 671 | Q9H0A0 | |
| LRVITAAVTVETSDH | 11 | P16112 | |
| HSSTEVTVEAREVTV | 2546 | Q5VST9 | |
| TRSLIEHVFVTDVTA | 496 | Q14781 | |
| EASLTNHTETITVEE | 16 | O95727 | |
| QDTTTVHISVEDVDE | 371 | Q9HBT6 | |
| VSSIAEHSVLSEVEA | 1451 | Q8N3K9 | |
| DHTTEISVSRLETVI | 71 | O60941 | |
| VITETRTEVVHVIRS | 2161 | Q12955 | |
| VNEVDVSEVVHSRAV | 186 | Q92796 | |
| EVETENVETVEASVH | 71 | Q15723 | |
| EETELEHTSTVVEVC | 851 | P10911 | |
| EHTSTVVEVCEAIAS | 856 | P10911 | |
| VSVFQEETVTLHCEV | 31 | P12314 | |
| HRILVASEVTTEITS | 26 | P60008 | |
| VHTETTEVVLTADPV | 466 | Q9Y3R0 | |
| RTSEISAVHIDTECV | 366 | Q9BY12 | |
| EHIEVTRIDGTIDSS | 1266 | Q92736 | |
| EHVVDVVVENSASRA | 906 | P98161 | |
| ITETLVSLRVHTVDD | 2646 | P98161 | |
| DSVSTMVVHDVEEIT | 861 | Q8N4C8 | |
| VQHTLTSVTDELAVA | 306 | P07332 | |
| LTRVTVVDTDVHVVY | 1076 | Q8N1G1 | |
| ATIARSEHEISEIID | 371 | O75376 | |
| RRHVSTAEETVQEEE | 176 | Q9P0U3 | |
| AVSHRTISEDSIEVL | 506 | Q8TEV9 | |
| ATHSASIQEETEEVV | 161 | Q9UGN4 | |
| VSAVAAVEEHVVSVS | 2151 | Q99973 | |
| AVEEHVVSVSRDGTL | 2156 | Q99973 | |
| TLEVDVEDVTASSRH | 226 | Q5TEJ8 | |
| VHSVKLVSTDTEDIV | 866 | Q17R98 | |
| HVEGTARLVTDTAEI | 211 | Q9Y6X8 | |
| TLSTVTHVIVDEVHE | 306 | Q9H6S0 | |
| NSRLQVEHTVTEEIT | 326 | P11498 | |
| VEHTVTEEITDVDLV | 331 | P11498 | |
| HIEEEETTSIATARR | 156 | Q14202 |